SWTX logo

SpringWorks Therapeutics (SWTX) Cash and cash equivalents

annual cash & cash equivalents:

$69.75M-$106.30M(-60.38%)
December 31, 2024

Summary

  • As of today (July 1, 2025), SWTX annual cash & cash equivalents is $69.75 million, with the most recent change of -$106.30 million (-60.38%) on December 31, 2024.
  • During the last 3 years, SWTX annual cash & cash equivalents has fallen by -$34.21 million (-32.91%).
  • SWTX annual cash & cash equivalents is now -78.71% below its all-time high of $327.65 million, reached on December 31, 2019.

Performance

SWTX Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXbalance sheet metrics

quarterly cash & cash equivalents:

$63.77M-$5.98M(-8.57%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX quarterly cash & cash equivalents is $63.77 million, with the most recent change of -$5.98 million (-8.57%) on March 31, 2025.
  • Over the past year, SWTX quarterly cash & cash equivalents has dropped by -$54.26 million (-45.97%).
  • SWTX quarterly cash & cash equivalents is now -86.61% below its all-time high of $476.43 million, reached on September 30, 2022.

Performance

SWTX quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

SWTX Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-60.4%-46.0%
3 y3 years-32.9%-22.2%
5 y5 years-78.7%-79.5%

SWTX Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-60.4%+3.4%-86.6%at low
5 y5-year-78.7%+3.4%-86.6%at low
alltimeall time-78.7%+579.1%-86.6%+39.7%

SWTX Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$63.77M(-8.6%)
Dec 2024
$69.75M(-60.4%)
$69.75M(-17.4%)
Sep 2024
-
$84.46M(+5.7%)
Jun 2024
-
$79.90M(-32.3%)
Mar 2024
-
$118.03M(-33.0%)
Dec 2023
$176.05M(+160.9%)
$176.05M(+78.0%)
Sep 2023
-
$98.89M(-14.0%)
Jun 2023
-
$115.00M(+12.3%)
Mar 2023
-
$102.40M(+51.7%)
Dec 2022
$67.49M(-35.1%)
$67.49M(-85.8%)
Sep 2022
-
$476.43M(+584.8%)
Jun 2022
-
$69.57M(-15.1%)
Mar 2022
-
$81.93M(-21.2%)
DateAnnualQuarterly
Dec 2021
$103.96M(-29.3%)
$103.96M(+10.8%)
Sep 2021
-
$93.85M(+11.0%)
Jun 2021
-
$84.57M(-11.4%)
Mar 2021
-
$95.43M(-35.1%)
Dec 2020
$147.09M(-55.1%)
$147.09M(+73.4%)
Sep 2020
-
$84.83M(-62.6%)
Jun 2020
-
$226.67M(-27.1%)
Mar 2020
-
$311.07M(-5.1%)
Dec 2019
$327.65M(+617.8%)
$327.65M(-4.7%)
Sep 2019
-
$343.82M(+85.6%)
Jun 2019
-
$185.29M(+305.9%)
Dec 2018
$45.65M(+344.4%)
$45.65M
Dec 2017
$10.27M
-

FAQ

  • What is SpringWorks Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics annual cash & cash equivalents year-on-year change?
  • What is SpringWorks Therapeutics quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics quarterly cash & cash equivalents year-on-year change?

What is SpringWorks Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of SWTX is $69.75M

What is the all time high annual cash & cash equivalents for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high annual cash & cash equivalents is $327.65M

What is SpringWorks Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, SWTX annual cash & cash equivalents has changed by -$106.30M (-60.38%)

What is SpringWorks Therapeutics quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of SWTX is $63.77M

What is the all time high quarterly cash & cash equivalents for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high quarterly cash & cash equivalents is $476.43M

What is SpringWorks Therapeutics quarterly cash & cash equivalents year-on-year change?

Over the past year, SWTX quarterly cash & cash equivalents has changed by -$54.26M (-45.97%)
On this page